Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP–4i) in US Adults with Type 2 Diabetes.

MLA

Tan, Xi, et al. “Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP–4i) in US Adults with Type 2 Diabetes.” Diabetes Therapy, vol. 15, no. 2, Feb. 2024, pp. 427–45. EBSCOhost, https://doi.org/10.1007/s13300-023-01509-y.

APA

Tan, X., Liang, Y., Gamble, C., & King, A. (2024). Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP–4i) in US Adults with Type 2 Diabetes. Diabetes Therapy, 15(2), 427–445. https://doi.org/10.1007/s13300-023-01509-y

Chicago

Tan, Xi, Yuanjie Liang, Cory Gamble, and Aaron King. 2024. “Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP–4i) in US Adults with Type 2 Diabetes.” Diabetes Therapy 15 (2): 427–45. doi:10.1007/s13300-023-01509-y.